Evidence map›Paper›PMID 42109264›Full record

ReviewAngewandte Chemie (International ed. in English)2026

Promiscuity-Guided Enzyme Evolution via Substrate Multiplexed Screening.

Holly A Weilbaker, Meghan E Campbell, Peyton M Higgins, Andrew R Buller

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Holly A WeilbakerDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0003-0042-0083
Meghan E CampbellDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Peyton M HigginsDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Andrew R BullerDepartment of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-9635-4844

Funding

Engineering promiscuous enzymes for synthesis of biological building blocksR35GM153276 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BULLER, ANDREW · 2024 to 2025
$800k
NIGMS NIH HHS R35 GM153276NIH HHS R35GM153276University of Wisconsin-Madison
6 · The paper itself

Abstract

An enzyme's ability to react with diverse substrates while maintaining high yield and selectivity, termed "substrate promiscuity," is a highly sought-after property in biocatalysts. Traditional directed evolution typically relies on single-substrate screening, which enables adaptive evolutionary pathways but provides limited information on promiscuity. This approach can inadvertently narrow substrate scope, and it is often unclear whether alternative mutational paths might have facilitated broader reactivity. Here, we review substrate multiplexed screening (SUMS), a strategy that places substrates in direct competition and quantifies multiple products simultaneously. When enzymes operate in competitive environments, such as living cells or multi-enzyme cascades, SUMS directly mirrors the intended use. We discuss how SUMS generates promiscuity information that can guide engineering, even when the final application involves individual substrates. Examples illustrate how SUMS can increase information density relative to parallel screening and, in select cases, reveal activity shifts that are invisible to single-substrate methods. We discuss the strengths and limitations of SUMS and highlight instances where its application led to enzymes with broad or complementary scopes, identified allosteric mutations, or enabled the circumvention of negative epistasis.

Indexed as

Directed Molecular EvolutionEnzymesBiocatalysisSubstrate SpecificityEnzymes

Identifiers

PMID42109264
PMCPMC13360519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.